Table 3.
Selectivity of six compounds on the typical biological targets of berberinea.
| Compd. | IC50 (μmol/L) |
|||
|---|---|---|---|---|
| β1 | D1 | D2 | 5-HT1B | |
| 8 | >100 | 5.56±0.08 | 17.87±0.86 | 47.16±1.22 |
| 15 | >100 | 1.61±0.13 | >100 | 40.83±0.80 |
| 18 | ∼100 | 1.71±0.10 | >100 | >100 |
| 21 | ∼100 | 2.35±0.07 | ∼50 | >100 |
| 22 | >100 | ∼100 | >100 | 13.43±0.51 |
| 24 | >100 | >100 | >100 | 15.70±0.59 |
| Berberine | – | 15.5b | 17.1b | – |
‒Not applicable.
Values are the average of 3 independent experiments. β1, beta-1 adrenergic receptor antagonist activity; D1, dopamine D1 antagonist activity; D2, dopamine D2 antagonist activity; 5-HT1B, serotonin 5-HT1B receptor antagonist activity.
Ref. 21.